Evidence map›Paper›PMID 39815175›Full record

ArticleBMC bioinformatics2025

Predicting drug combination side effects based on a metapath-based heterogeneous graph neural network.

Leixia Tian, Qi Wang, Zhiheng Zhou, Xiya Liu, Ming Zhang, Guiying Yan

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leixia Tian *Beijing School, Beijing, 100088, China.
Qi Wang *College of Science, China Agricultural University, Beijing, 100083, China.
Zhiheng ZhouAcademy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China.
Xiya LiuInstitute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Ming ZhangAcademy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China.
Guiying YanAcademy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China. yangy@amss.ac.cn.

Funding

the National Natural Science Foundation of China 12231018
6 · The paper itself

Abstract

In recent years, combined drug screening has played a very important role in modern drug discovery. Generally, synergistic drug combinations are crucial in treatment for many diseases. However, the toxic side effects of drug combinations are probably increased with the increase of drugs numbers, so the accurate prediction of toxic side effects of drug combinations is equally important. In this paper, we built a Metapath-based Aggregated Embedding Model on Single Drug-Side Effect Heterogeneous Information Network (MAEM-SSHIN), which extracts feature from a heterogeneous information network of single drug side effects, and a Graph Convolutional Network on Combinatorial drugs and Side effect Heterogeneous Information Network (GCN-CSHIN), which transforms the complex task of predicting multiple side effects between drug pairs into the more manageable prediction of relationships between combinatorial drugs and individual side effects. MAEM-SSHIN and GCN-CSHIN provided a united novel framework for predicting potential side effects in combinatorial drug therapies. This integration enhances prediction accuracy, efficiency, and scalability. Our experimental results demonstrate that this combined framework outperforms existing methodologies in predicting side effects, and marks a significant advancement in pharmaceutical research.

Indexed as

Drug-Related Side Effects and Adverse ReactionsNeural Networks, ComputerAlgorithmsComputational BiologyDrug CombinationsDrug DiscoveryGraph Neural NetworksHumansDrug CombinationsCombinatorial drugsGraph convolutional networkHeterogeneous information networkMetapathSide effect prediction

Identifiers

PMID39815175
PMCPMC11734363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.